Lv11
100 积分 2025-01-20 加入
Hidradenitis Suppurativa
6小时前
待确认
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa
1个月前
已关闭
Roenigk & Roenigk's Dermatologic Surgery: Principles and Practice
1个月前
已完结
Vixarelimab in Patients With Prurigo Nodularis
1个月前
已完结
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
1个月前
已完结
Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience
1个月前
已完结
The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
1个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
3个月前
已完结
Large-vessel vasculitis
4个月前
已完结
[Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment]
4个月前
已完结
皖公网安备34019202002308
